Holdings
46
Concentrated
Top 10 weight
43%
Concentration
Strategy
Active
Portfolio style
Equity
96%
Asset allocation
Portfolio
4Sectors2Large positions69.5%Top: Pharmaceuticals & Biotechnology0.0%Cash
Market-cap allocation
Large cap25%
Mid cap23%
Small cap46%
Asset allocation
Equity96%
Top holdings
EQ - SUN PHARMACEUTICALS INDUSTRIESEQUITY8.7%
EQ - DIVIS LABORATORIES LTD.EQUITY5.6%
EQ - AJANTA PHARMA LTD.EQUITY4.8%
EQ - CAPLIN POINT LABORATORIES LTDEQUITY4.0%
EQ - LUPIN LTD.EQUITY3.6%
EQ - GLAND PHARMA LTD.EQUITY3.6%
EQ - APOLLO HOSPITALS ENTERPRISE LTEQUITY3.5%
EQ - ALKEM LABORATORIES LTDEQUITY3.1%
EQ - DR REDDYS LABORATORIES LTD.EQUITY3.1%
NET CURRENT ASSETSDERIVATIVE2.9%
Sign in for free to unlock all 46 holdings →Portfolio insights
Portfolio read
- 96% equity.
- Large-cap exposure is 25%.
- Largest equity sector is Pharmaceuticals & Biotechnology at 69.5%.
Watchpoints
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 69%.
Generated from current fund metrics. Educational research only.
Peer comparison
Other funds in Sectoral / Thematic.
Explore comparable funds →Sector exposure
Showing top sectors from the current portfolio.
Healthcare Services24.0%